The weights of harvested tumors were consistent with the bioluminescence results, showing that combination of the CCP/PCBP2 siRNA nanocomplex and gemcitabine chemotherapy resulted in a 72.3% reduction in tumor weights (Figure 7D-E). Here, PCBP2 is linked to neoplasm.